Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Benefits and harms of aspirin to reduce colorectal cancer risk: a cross-sectional study of methods to communicate risk in primary care.

Nguyen P, McIntosh J, Bickerstaffe A, Maddumarachchi S, Cummings KL, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e843-e849. doi: 10.3399/bjgp19X706613. Print 2019 Dec.

PMID:
31740461
2.

Decision support tools to improve cancer diagnostic decision making in primary care: a systematic review.

Chima S, Reece JC, Milley K, Milton S, McIntosh JG, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e809-e818. doi: 10.3399/bjgp19X706745. Print 2019 Dec.

PMID:
31740460
3.

Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.

McIntosh JG, Minshall J, Saya S, Bickerstaffe A, Hewabandu N, Qama A, Emery JD.

Br J Gen Pract. 2019 Nov 28;69(689):e836-e842. doi: 10.3399/bjgp19X706841. Print 2019 Dec.

PMID:
31636127
4.

Microfluidic electrochemical cell for in situ structural characterization of amorphous thin-film catalysts using high-energy X-ray scattering.

Kwon G, Cho YH, Kim KB, Emery JD, Kim IS, Zhang X, Martinson ABF, Tiede DM.

J Synchrotron Radiat. 2019 Sep 1;26(Pt 5):1600-1611. doi: 10.1107/S1600577519007240. Epub 2019 Aug 9.

5.

Tools to facilitate communication during physician-patient consultations in cancer care: An overview of systematic reviews.

Licqurish SM, Cook OY, Pattuwage LP, Saunders C, Jefford M, Koczwara B, Johnson CE, Emery JD.

CA Cancer J Clin. 2019 Nov;69(6):497-520. doi: 10.3322/caac.21573. Epub 2019 Jul 24. Review.

6.

Risk Prediction Models for Colorectal Cancer Incorporating Common Genetic Variants: A Systematic Review.

McGeoch L, Saunders CL, Griffin SJ, Emery JD, Walter FM, Thompson DJ, Antoniou AC, Usher-Smith JA.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1580-1593. doi: 10.1158/1055-9965.EPI-19-0059. Epub 2019 Jul 10. Review.

PMID:
31292139
7.

The CRISP-P study: feasibility of a self-completed colorectal cancer risk prediction tool in primary care.

Harty EC, McIntosh JG, Bickerstaffe A, Hewabandu N, Emery JD.

Fam Pract. 2019 Nov 18;36(6):730-735. doi: 10.1093/fampra/cmz029.

PMID:
31237329
8.

Chemoprevention: A new concept for cancer prevention in primary care

Emery JD, Nguyen P, Minshall J, Cummings KL, Walker J.

Aust J Gen Pract. 2018 Dec;47(12):825-828. doi: 10.31128/AJGP-07-18-4644.

9.

Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family history.

Jenkins MA, Win AK, Dowty JG, MacInnis RJ, Makalic E, Schmidt DF, Dite GS, Kapuscinski M, Clendenning M, Rosty C, Winship IM, Emery JD, Saya S, Macrae FA, Ahnen DJ, Duggan D, Figueiredo JC, Lindor NM, Haile RW, Potter JD, Cotterchio M, Gallinger S, Newcomb PA, Buchanan DD, Casey G, Hopper JL.

Fam Cancer. 2019 Oct;18(4):389-397. doi: 10.1007/s10689-019-00136-6.

PMID:
31209717
10.

Evaluating diagnostic strategies for early detection of cancer: the CanTest framework.

Walter FM, Thompson MJ, Wellwood I, Abel GA, Hamilton W, Johnson M, Lyratzopoulos G, Messenger MP, Neal RD, Rubin G, Singh H, Spencer A, Sutton S, Vedsted P, Emery JD.

BMC Cancer. 2019 Jun 14;19(1):586. doi: 10.1186/s12885-019-5746-6.

11.

Lung cancer.

Neal RD, Sun F, Emery JD, Callister ME.

BMJ. 2019 Jun 3;365:l1725. doi: 10.1136/bmj.l1725. No abstract available.

12.

Understanding implementation and usefulness of electronic clinical decision support (eCDS) for melanoma in English primary care: a qualitative investigation.

Pannebakker MM, Mills K, Johnson M, Emery JD, Walter FM.

BJGP Open. 2019 Mar 20;3(1):bjgpopen18X101635. doi: 10.3399/bjgpopen18X101635. eCollection 2019 Apr.

13.

Gathering data for decisions: best practice use of primary care electronic records for research.

Canaway R, Boyle DI, Manski-Nankervis JE, Bell J, Hocking JS, Clarke K, Clark M, Gunn JM, Emery JD.

Med J Aust. 2019 Apr;210 Suppl 6:S12-S16. doi: 10.5694/mja2.50026.

14.

The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer.

Emery JD, Murray SR, Walter FM, Martin A, Goodall S, Mazza D, Habgood E, Kutzer Y, Barnes DJ, Murchie P.

Thorax. 2019 Apr;74(4):362-370. doi: 10.1136/thoraxjnl-2018-212506. Epub 2019 Jan 10.

15.

Consumer and clinician perspectives on personalising breast cancer prevention information.

Keogh LA, Steel E, Weideman P, Butow P, Collins IM, Emery JD, Mann GB, Bickerstaffe A, Trainer AH, Hopper LJ, Phillips KA.

Breast. 2019 Feb;43:39-47. doi: 10.1016/j.breast.2018.11.002. Epub 2018 Nov 7.

PMID:
30445378
16.

Revised Australian national guidelines for colorectal cancer screening: family history.

Jenkins MA, Ait Ouakrim D, Boussioutas A, Hopper JL, Ee HC, Emery JD, Macrae FA, Chetcuti A, Wuellner L, St John DJB.

Med J Aust. 2018 Nov 19;209(10):455-460. Epub 2018 Oct 29.

PMID:
30359558
17.

The influence of health literacy on the timely diagnosis of symptomatic cancer: A systematic review.

Humphrys E, Burt J, Rubin G, Emery JD, Walter FM.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12920. doi: 10.1111/ecc.12920. Epub 2018 Oct 16.

18.

Benefits, Harms, and Cost-Effectiveness of Potential Age Extensions to the National Bowel Cancer Screening Program in Australia.

Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Greuter MJE, Coupé VMH, Canfell K.

Cancer Epidemiol Biomarkers Prev. 2018 Dec;27(12):1450-1461. doi: 10.1158/1055-9965.EPI-18-0128. Epub 2018 Sep 6.

19.

Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios.

Dillon M, Flander L, Buchanan DD, Macrae FA, Emery JD, Winship IM, Boussioutas A, Giles GG, Hopper JL, Jenkins MA, Ait Ouakrim D.

PLoS Med. 2018 Aug 16;15(8):e1002630. doi: 10.1371/journal.pmed.1002630. eCollection 2018 Aug.

20.

The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial.

Walker JG, Macrae F, Winship I, Oberoi J, Saya S, Milton S, Bickerstaffe A, Dowty JG, De Abreu Lourenço R, Clark M, Galloway L, Fishman G, Walter FM, Flander L, Chondros P, Ait Ouakrim D, Pirotta M, Trevena L, Jenkins MA, Emery JD.

Trials. 2018 Jul 25;19(1):397. doi: 10.1186/s13063-018-2764-7.

21.
22.

'Why don't I need a colonoscopy?' A novel approach to communicating risks and benefits of colorectal cancer screening.

Emery JD, Pirotta M, Macrae F, Walker JG, Qama A, Jenkins M, Boussioutas A.

Aust J Gen Pract. 2018 Jun;47(6):343-349. doi: 10.31128/AJGP-11-17-4386.

23.

Resolving the Chemically Discrete Structure of Synthetic Borophene Polymorphs.

Campbell GP, Mannix AJ, Emery JD, Lee TL, Guisinger NP, Hersam MC, Bedzyk MJ.

Nano Lett. 2018 May 9;18(5):2816-2821. doi: 10.1021/acs.nanolett.7b05178. Epub 2018 Apr 23.

PMID:
29653052
24.

The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening

Kim GY, Walker JG, Bickerstaffe A, Hewabandu N, Pirotta M, Flander L, Jenkins M, Emery JD.

Aust J Gen Pract. 2018 Mar;47(3):139-145. doi: 10.31128/AFP-04-17-4195.

25.

The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia.

Emery JD, Gray V, Walter FM, Cheetham S, Croager EJ, Slevin T, Saunders C, Threlfall T, Auret K, Nowak AK, Geelhoed E, Bulsara M, Holman CDJ.

Br J Cancer. 2018 Mar 20;118(6):e8. doi: 10.1038/bjc.2017.457. Epub 2018 Feb 15.

26.

Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.

Lew JB, St John DJB, Macrae FA, Emery JD, Ee HC, Jenkins MA, He E, Grogan P, Caruana M, Sarfati D, Greuter MJE, Coupé VMH, Canfell K.

Int J Cancer. 2018 Jul 15;143(2):269-282. doi: 10.1002/ijc.31314. Epub 2018 Mar 8.

27.

Mechanistic understanding of tungsten oxide in-plane nanostructure growth via sequential infiltration synthesis.

Kim JJ, Suh HS, Zhou C, Mane AU, Lee B, Kim S, Emery JD, Elam JW, Nealey PF, Fenter P, Fister TT.

Nanoscale. 2018 Feb 15;10(7):3469-3479. doi: 10.1039/c7nr07642h.

PMID:
29404547
28.

Measuring Dipole Inversion in Self-Assembled Nano-Dielectric Molecular Layers.

Zeng L, Turrisi R, Fu B, Emery JD, Walker AR, Ratner MA, Hersam MC, Facchetti AF, Marks TJ, Bedzyk MJ.

ACS Appl Mater Interfaces. 2018 Feb 21;10(7):6484-6490. doi: 10.1021/acsami.7b16160. Epub 2018 Feb 12.

PMID:
29378110
29.

Fragile X population carrier screening.

Metcalfe SA, Delatycki MB, Cohen J, Archibald AD, Emery JD.

Genet Med. 2018 Sep;20(9):1091-1092. doi: 10.1038/gim.2017.209. No abstract available.

PMID:
29215647
30.

Lung cancer in Asian women and health system implications for Australia.

Emery JD, Mitchell PL.

Lancet Oncol. 2017 Dec;18(12):1570-1571. doi: 10.1016/S1470-2045(17)30853-7. No abstract available.

PMID:
29208428
31.

Reducing barriers to consulting a General Practitioner in patients at increased risk of lung cancer: a qualitative evaluation of the CHEST Australia intervention.

Murray SR, Kutzer Y, Habgood E, Murchie P, Walter FM, Mazza D, Shahid S, Emery JD.

Fam Pract. 2017 Nov 16;34(6):740-746. doi: 10.1093/fampra/cmx057.

32.

Provider Roles in Survivorship Care: Moving Beyond Surveys of Patient Preference.

Lisy K, Emery JD, Jefford M.

J Clin Oncol. 2017 Dec 1;35(34):3890. doi: 10.1200/JCO.2017.75.7187. Epub 2017 Oct 12. No abstract available.

PMID:
29023216
33.

Pharmacogenomic Testing and Warfarin: What Evidence Has the GIFT Trial Provided?

Emery JD.

JAMA. 2017 Sep 26;318(12):1110-1112. doi: 10.1001/jama.2017.11465. No abstract available.

PMID:
28973596
34.

The Improving Rural Cancer Outcomes Trial: a cluster-randomised controlled trial of a complex intervention to reduce time to diagnosis in rural cancer patients in Western Australia.

Emery JD, Gray V, Walter FM, Cheetham S, Croager EJ, Slevin T, Saunders C, Threlfall T, Auret K, Nowak AK, Geelhoed E, Bulsara M, Holman CDJ.

Br J Cancer. 2017 Nov 7;117(10):1459-1469. doi: 10.1038/bjc.2017.310. Epub 2017 Sep 19. Erratum in: Br J Cancer. 2018 Feb 15;:.

35.

Understanding symptom appraisal and help-seeking in people with symptoms suggestive of pancreatic cancer: a qualitative study.

Mills K, Birt L, Emery JD, Hall N, Banks J, Johnson M, Lancaster J, Hamilton W, Rubin GP, Walter FM.

BMJ Open. 2017 Sep 3;7(9):e015682. doi: 10.1136/bmjopen-2016-015682.

36.

Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening.

Metcalfe SA, Martyn M, Ames A, Anderson V, Archibald AD, Couns GDG, Carter R, Cohen J, Cotter M, GenCouns M, Dang W, Delatycki MB, Donath S, Edwards S, Educ PD, Couns GDG, Forbes R, Couns GDG, Gavrila M, MedSci M, Halliday J, Hickerton C, Hill M, Couns GDG, Jacobs L, Ultrasound PD, Petrou V, Couns GDG, Plunkett L, GenCouns M, Sheffield L, Racp F, Thornton A, Couns GDG, Younie S, Econ PDH, Emery JD.

Genet Med. 2017 Dec;19(12):1346-1355. doi: 10.1038/gim.2017.67. Epub 2017 Jun 29.

PMID:
28661491
37.

Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study.

Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, Cross H, Krishnasamy M, McLachlan SA, Bishop J.

Support Care Cancer. 2017 Oct;25(10):3171-3179. doi: 10.1007/s00520-017-3725-5. Epub 2017 Apr 22.

PMID:
28434095
38.

Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study.

Walter FM, Mills K, Mendonça SC, Abel GA, Basu B, Carroll N, Ballard S, Lancaster J, Hamilton W, Rubin GP, Emery JD.

Lancet Gastroenterol Hepatol. 2016 Dec;1(4):298-306. doi: 10.1016/S2468-1253(16)30079-6. Epub 2016 Oct 4.

39.

Inhibiting Metal Oxide Atomic Layer Deposition: Beyond Zinc Oxide.

Sampson MD, Emery JD, Pellin MJ, Martinson ABF.

ACS Appl Mater Interfaces. 2017 Oct 4;9(39):33429-33436. doi: 10.1021/acsami.7b01410. Epub 2017 Apr 5.

PMID:
28379011
40.

Low-Temperature Atomic Layer Deposition of MoS2 Films.

Jurca T, Moody MJ, Henning A, Emery JD, Wang B, Tan JM, Lohr TL, Lauhon LJ, Marks TJ.

Angew Chem Int Ed Engl. 2017 Apr 24;56(18):4991-4995. doi: 10.1002/anie.201611838. Epub 2017 Apr 3.

PMID:
28371057
41.

Low-Temperature Atomic Layer Deposition of CuSbS2 for Thin-Film Photovoltaics.

Riha SC, Koegel AA, Emery JD, Pellin MJ, Martinson AB.

ACS Appl Mater Interfaces. 2017 Feb 8;9(5):4667-4673. doi: 10.1021/acsami.6b13033. Epub 2017 Jan 24.

PMID:
28117960
42.

The CRISP colorectal cancer risk prediction tool: an exploratory study using simulated consultations in Australian primary care.

Walker JG, Bickerstaffe A, Hewabandu N, Maddumarachchi S, Dowty JG; CRECRC, Jenkins M, Pirotta M, Walter FM, Emery JD.

BMC Med Inform Decis Mak. 2017 Jan 19;17(1):13. doi: 10.1186/s12911-017-0407-7.

43.

Identifying people at higher risk of melanoma across the U.K.: a primary-care-based electronic survey.

Usher-Smith JA, Kassianos AP, Emery JD, Abel GA, Teoh Z, Hall S, Neal RD, Murchie P, Walter FM.

Br J Dermatol. 2017 Apr;176(4):939-948. doi: 10.1111/bjd.15181. Epub 2016 Dec 23.

44.

Conformal Coating of a Phase Change Material on Ordered Plasmonic Nanorod Arrays for Broadband All-Optical Switching.

Guo P, Weimer MS, Emery JD, Diroll BT, Chen X, Hock AS, Chang RP, Martinson AB, Schaller RD.

ACS Nano. 2017 Jan 24;11(1):693-701. doi: 10.1021/acsnano.6b07042. Epub 2016 Dec 19.

PMID:
27991757
45.

Liquid Water- and Heat-Resistant Hybrid Perovskite Photovoltaics via an Inverted ALD Oxide Electron Extraction Layer Design.

Kim IS, Cao DH, Buchholz DB, Emery JD, Farha OK, Hupp JT, Kanatzidis MG, Martinson AB.

Nano Lett. 2016 Dec 14;16(12):7786-7790. Epub 2016 Nov 14.

46.

Layer-by-Layer Assembled Films of Perylene Diimide- and Squaraine-Containing Metal-Organic Framework-like Materials: Solar Energy Capture and Directional Energy Transfer.

Park HJ, So MC, Gosztola D, Wiederrecht GP, Emery JD, Martinson AB, Er S, Wilmer CE, Vermeulen NA, Aspuru-Guzik A, Stoddart JF, Farha OK, Hupp JT.

ACS Appl Mater Interfaces. 2016 Sep 28;8(38):24983-8. doi: 10.1021/acsami.6b03307. Epub 2016 Sep 16.

PMID:
27617568
47.

Operating Room-to-ICU Patient Handovers: A Multidisciplinary Human-Centered Design Approach.

Segall N, Bonifacio AS, Barbeito A, Schroeder RA, Perfect SR, Wright MC, Emery JD, Atkins BZ, Taekman JM, Mark JB.

Jt Comm J Qual Patient Saf. 2016 Sep;42(9):400-14.

48.

Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study.

Walter FM, Emery JD, Mendonca S, Hall N, Morris HC, Mills K, Dobson C, Bankhead C, Johnson M, Abel GA, Rutter MD, Hamilton W, Rubin GP.

Br J Cancer. 2016 Aug 23;115(5):533-41. doi: 10.1038/bjc.2016.221. Epub 2016 Aug 4.

49.

Presentations to general practice before a cancer diagnosis in Victoria: a cross-sectional survey.

Lacey K, Bishop JF, Cross HL, Chondros P, Lyratzopoulos G, Emery JD.

Med J Aust. 2016 Jul 18;205(2):66-71.

PMID:
27456447
50.

Porphyrins as Templates for Site-Selective Atomic Layer Deposition: Vapor Metalation and in Situ Monitoring of Island Growth.

Avila JR, Emery JD, Pellin MJ, Martinson AB, Farha OK, Hupp JT.

ACS Appl Mater Interfaces. 2016 Aug 10;8(31):19853-9. doi: 10.1021/acsami.6b05427. Epub 2016 Jul 28.

PMID:
27454741

Supplemental Content

Loading ...
Support Center